Philip S. Bergman
- Co-authors
- M NathansonPaul J. AndersonLouis R. OrkinMartin A. GreenS. Bernard WortisMorris B. BenderPeter R. MahrerSolomon Estren
- Topics
- Epilepsy research and treatment (3 papers)Botulinum Toxin and Related Neurological Disorders (2 papers)Glaucoma and retinal disorders (2 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Philip S. Bergman
19 papers receiving 215 citations
Peers
Comparison fields: 5 of 75
- Neurology 69
- Neurology 61
- Cognitive Neuroscience 60
- Psychiatry and Mental health 49
- Epidemiology 36
Countries citing papers authored by Philip S. Bergman
This map shows the geographic impact of Philip S. Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip S. Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip S. Bergman more than expected).
Fields of papers citing papers by Philip S. Bergman
This network shows the impact of papers produced by Philip S. Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip S. Bergman. The network helps show where Philip S. Bergman may publish in the future.
Co-authorship network of co-authors of Philip S. Bergman
This figure shows the co-authorship network connecting the top 25 collaborators of Philip S. Bergman. A scholar is included among the top collaborators of Philip S. Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip S. Bergman. Philip S. Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 28 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 11 | |
| 6 | 16 | |
| 7 | 17 | |
| 8 | 36 | |
| 9 | 26 | |
| 10 | 2 | |
| 11 | 23 | |
| 12 | 10 | |
| 13 | 3 | |
| 14 | 4 | |
| 15 | 4 | |
| 16 | 40 | |
| 17 | 23 | |
| 18 | 10 | |
| 19 | 9 | |
| 20 | 7 |
About Philip S. Bergman
Philip S. Bergman is a scholar working on Neurology, Psychiatry and Mental health and Neurology, having authored 21 papers that have together received 286 indexed citations. Recurring topics across this work include Epilepsy research and treatment (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers) and Glaucoma and retinal disorders (2 papers). The work is most often cited by research in Neurology (69 citations), Neurology (61 citations) and Psychiatry and Mental health (49 citations). Philip S. Bergman has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include M Nathanson, Paul J. Anderson, Louis R. Orkin, Martin A. Green, S. Bernard Wortis, Morris B. Bender, Peter R. Mahrer, Solomon Estren, Sidney Diamond and Leonard I. Malis. Their work appears in journals such as JAMA, American Journal of Psychiatry and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.